Patent 7897146 was granted and assigned to Crusade Laboratories Ltd. on March, 2011 by the United States Patent and Trademark Office.
The use of Herpes Simplex Virus (HSV) in the treatment of tumour by extratumoural administration of HSV, and the use of HSV in treatment of tumour by combination therapy with a pharmaceutical wherein the HSV and/or pharmaceutical is administered at an extratumoural location, is disclosed.